Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T14:47:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing clearer information on who to contact for questions and where the study is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    0.9%
    Check dated 2024-12-10T13:15:52.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    New entries for MK-3475-756 have been added, while previous entries related to the same identifier and various study details have been removed.
    Difference
    2%
    Check dated 2024-11-25T21:18:21.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    1%
    Check dated 2024-11-18T11:26:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated from version v2.11.2 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-04T09:34:18.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements in the latest release.
    Difference
    0.0%
    Check dated 2024-10-03T05:48:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.